Drug resistance in cancer
- PMID: 16234820
- PMCID: PMC2361669
- DOI: 10.1038/sj.bjc.6602821
Drug resistance in cancer
Abstract
Cancer Research UK has recently sponsored a meeting, organized by the UK Medical Research Council, on cancer drug resistance. Several of the molecular mechanisms responsible for this clinical outcome, such as DNA interstrand crosslink repair, apoptosis evasion, cytochrome P450 and P-glycoprotein, were discussed. There was a special focus on leukaemia, breast and ovarian cancer, and the potential use of positron-emission tomography to study anticancer-drug resistance. The progress made in translating these findings to the clinic, like Gefitinib, P-glycoprotein phenotyping, or genome-wide analysis technology, was also discussed.
Similar articles
-
Mechanisms of multidrug resistance in cancer.Methods Mol Biol. 2010;596:47-76. doi: 10.1007/978-1-60761-416-6_4. Methods Mol Biol. 2010. PMID: 19949920
-
Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.Cancer Chemother Pharmacol. 2010 Aug;66(3):585-96. doi: 10.1007/s00280-009-1200-9. Epub 2009 Dec 18. Cancer Chemother Pharmacol. 2010. PMID: 20020128
-
Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics.Drug Resist Updat. 2016 Sep;28:65-81. doi: 10.1016/j.drup.2016.07.001. Epub 2016 Jul 16. Drug Resist Updat. 2016. PMID: 27620955 Review.
-
Cisplatin resistance: preclinical findings and clinical implications.Biochim Biophys Acta. 2010 Dec;1806(2):172-82. doi: 10.1016/j.bbcan.2010.07.004. Epub 2010 Jul 17. Biochim Biophys Acta. 2010. PMID: 20647037 Review.
-
Introduction to resistance to anticancer agents.Oncogene. 2003 Oct 20;22(47):7262-4. doi: 10.1038/sj.onc.1206932. Oncogene. 2003. PMID: 14576836 Review. No abstract available.
Cited by
-
Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.Brief Bioinform. 2021 Nov 5;22(6):bbab229. doi: 10.1093/bib/bbab229. Brief Bioinform. 2021. PMID: 34111889 Free PMC article.
-
Immune Checkpoint Inhibitors: A Narrative Review on PD-1/PD-L1 Blockade Mechanism, Efficacy, and Safety Profile in Treating Malignancy.Cureus. 2024 Apr 12;16(4):e58138. doi: 10.7759/cureus.58138. eCollection 2024 Apr. Cureus. 2024. PMID: 38738146 Free PMC article. Review.
-
Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.PLoS One. 2013 May 2;8(5):e62289. doi: 10.1371/journal.pone.0062289. Print 2013. PLoS One. 2013. PMID: 23658721 Free PMC article.
References
-
- Agarwal R, Kaye SB (2003) Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3: 502–516 - PubMed
-
- Essafi A, Fernandez de Mattos S, Hassen YA, Soeiro I, Mufti GJ, Thomas NS, Medema RH, Lam EW (2005) Direct transcriptional regulation of Bim by FoxO3a mediates ST1571-induced apoptosis in Ber-Abl-expressing cells. Oncogene 24: 2317–2329 - PubMed
-
- Hahn WC, Weinberg RA (2002) Modelling the molecular circuitry of cancer. Nat Rev Cancer 2: 331–341 - PubMed
-
- Irving JA, Bloodworth L, Bown NP, Case MC, Hogarth LA, Hall AG (2005) Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis. Cancer Res 65: 3053–3058 - PubMed
-
- Martens JW, Nimmrich I, Koenig T, Look MP, Harbeck N, Model F, Kluth A, Bolt-de Vries J, Sieuwerts AM, Portengen H, Meijer-Van Gelder ME, Piepenbrock C, Olek A, Hofler H, Kiechle M, Klijn JG, Schmitt M, Maier S, Foekens JA (2005) Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res 65: 4101–4117 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources